Disseminated tuberculosis after Polatuzumab‐Vedotin based chemoimmunotherapy in a patient with Burkitt's lymphoma
<p dir="ltr">This report highlights the risk of latent tuberculosis (TB) reactivation after treatment with Polatuzumab Vedotin (PV), Rituximab, and Bendamustine (PBR protocol) despite appropriate chemoprophylaxis. A 48‐year‐old male with refractory Burkitt's lymphoma (BKL) was t...
Saved in:
| Main Author: | Sarah A. Elkourashy (21632903) (author) |
|---|---|
| Other Authors: | Maria Benkhadra (19756941) (author), Laila Shafei (17045772) (author), Sulieman Abujarir (21632906) (author), Rola Ghasoub (16555851) (author) |
| Published: |
2024
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report
by: Meshaal Alanzi (21406994)
Published: (2023) -
The microbiome-lymphoma Axis: A systematic review and Meta-analysis of gut Dysbiosis pattern in diffuse large B-cell lymphoma
by: Sarah A. Elkourashy (21632903)
Published: (2025) -
Disseminated tuberculosis complicated by hemophagocytic lymphohistiocytosis in an immunocompetent adult with favorable outcomes: A case report
by: Abdulrahman F. Al-Mashdali (17148316)
Published: (2022) -
Cavitary pulmonary tuberculosis with COVID-19 coinfection
by: Zohaib Yousaf (9617058)
Published: (2020) -
Efficacy and safety of ibrutinib in central nervous system lymphoma: A systematic review and meta-analysis
by: Jaber H. Jaradat (21632849)
Published: (2024)